JOHN F ZWETCHKENBAUM

Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy PROVIDENCE, RI NPI 1124027552

General Payments — all program years on this page

$198,561.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 115
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $193,326.93 across 25 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CIPLA USA INC. $192,920.008
GlaxoSmithKline, LLC. $145.908
GENZYME CORPORATION $100.011
NOVARTIS PHARMACEUTICALS CORPORATION $71.254
Acerta Pharma LLC $68.813
Grifols USA, LLC $20.961

By program year

Program yearAmountRecords
2018 $1,693.5225
2019 $2,039.1121
2020 $766.8214
2021 $260.3514
2022 $413.0413
2023 $62.013
2024 $193,326.9325

Records — PY2024 (25)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087378552 Novartis Pharmaceuticals Corporation $16.67 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087378562 Novartis Pharmaceuticals Corporation $15.41 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087378566 Novartis Pharmaceuticals Corporation $18.43 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087378568 Novartis Pharmaceuticals Corporation $20.74 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105664854 AstraZeneca Pharmaceuticals LP $23.32 10/15/2024 Education Undisputed 01/23/2026 View at CMS
1105695886 AstraZeneca Pharmaceuticals LP $21.72 10/15/2024 Education Undisputed 01/23/2026 View at CMS
1105816975 AstraZeneca Pharmaceuticals LP $23.77 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115884268 GlaxoSmithKline, LLC. $28.83 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116267992 GlaxoSmithKline, LLC. $7.33 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116290941 GlaxoSmithKline, LLC. $25.20 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116318572 GlaxoSmithKline, LLC. $10.44 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116399694 GlaxoSmithKline, LLC. $27.40 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116616748 GlaxoSmithKline, LLC. $10.31 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116618563 GlaxoSmithKline, LLC. $27.72 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116681719 GlaxoSmithKline, LLC. $8.67 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124732833 Grifols USA, LLC $20.96 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139625554 GENZYME CORPORATION $100.01 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154015197 CIPLA USA INC. $16,400.00 06/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015207 CIPLA USA INC. $20,320.00 07/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015209 CIPLA USA INC. $50,540.00 08/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015211 CIPLA USA INC. $30,990.00 09/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015213 CIPLA USA INC. $11,200.00 09/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015215 CIPLA USA INC. $25,220.00 12/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015217 CIPLA USA INC. $3,250.00 12/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1154015289 CIPLA USA INC. $35,000.00 02/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.